Stay updated with breaking news from Goodwin Procter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Transaction to include felzartamab, a potential first-in-class therapeutic candidate with promise as a pipeline-in-a-product across a range of immune-mediated diseasesFelzartamab is an investigational
Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK and SOUTH SAN FRANCISCO,...
It was only a matter of time before Forbes - the list mavens - would come out with a list of America's Top lawyers and their list of America's Top 200 lawyers
/PRNewswire/ -- Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, today announced that...
The combined company will leverage the strengths from each organization aiming to take AI-driven security operations to new heights.